Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: A randomized, double-blind, parallel group study

International Clinical Psychopharmacology

Volumn 16, Issue 6, 2001, Pages 317-324

  Amore, Mario ^a   Jori, M C ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b Sanofi Midy Research Center   (Italy)

Author keywords

Amisulpride; Dysthymia; Onset of action; Sertraline

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; DYSTHYMIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

EID: 0034753690     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200111000-00001     Document Type: Article

References (43)

1. Dysthymia. Options in pharmacotherapy
2. Amisulpride versus amineptine and placebo for the treatment of dysthymia
3. Depressive neurosis. A long-term prospective and retrospective follow-up study of former inpatients
4. Social adjustment in dysthymia
5. Amisulpride. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of schizophrenia
6. Early onset of antidepressant action: Impact on primary care
7. How fast are antidepressants?
8. Form and frequency of mental disorders across centres
9. Revising axis V for DSM-IV: A review of measures of social functioning (SOFAS)
10. CGI, Clinical Global Impression
11. The assessment of anxiety states by rating
12. A rating scale for depression
13. Onset of action in the pharmacologic treatment of dysthymia
14. Course, outcome and impact on the community
15. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States
16. Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study
17. Responsiveness of abserver rating scales by analysis of number of days until improvement in patients with major depression
18. Social adjustment in dysthymia, double-depression and episodi major depression
19. Amisulpride versus imipramine and placebo in dysthymic patients
20. An ideal trial to test differential onset of antidepressant effect
21. How to assess the onset of antidepressant effect: Comparison of global ratings and findings based on depression scales
22. A new depression scale designed to be sensitive to change
23. Are 2-week trials sufficient to indicate efficacy?
24. The failure of placebo-controlled studies
25. A regression analytical approach to estimate the onset of activity of antidepressants
26. Timing of onset of antidepressant response with fluoxetine treatment
27. Amisulpride. A review of its clinical potential in dysthymia
28. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment
29. Treatment of dysthymia with sertraline: A double-blind, placebo-controlled trial in dsythymic patients without major depression
30. Amisulpride in medium-term treatment of dysthymia: A six month, double-blind, safety study versus amitriptyline
31. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity
32. Role of the mesolimbic dopaine system in the mechanism of action of antidepressants
33. Amisulpride versus fluoxetine in patients with dysthymia or major depression in partial remission. A double-blind comparative study
34. The epidemiology of depressive disorders: National and international perspectives
35. Evidence of early onset of antidepressant effect in randomized controlled trials
36. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline
37. Time course of improvement under antidepressant treatment: A survival-analytical approach
38. Delayed onset of action of antidepressant drugs? Survey of recent results
39. A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia
40. Paroxetine and pindolol: A randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency
41. The chronic depressive in the community: Under-recognized and poorly treated
42. The epidemiology of dysthymia in five communities: Rates, risks, comorbidity and treatment
43. Comparing speed of effectiveness of two treatments